Skip to main content


In some countries, this medicine may only be approved for veterinary use.

In the US, Cyclizine is a member of the drug class anticholinergic antiemetics and is used to treat Motion Sickness and Nausea/Vomiting.



ATC (Anatomical Therapeutic Chemical Classification)


CAS registry number (Chemical Abstracts Service)


Chemical Formula


Molecular Weight


Therapeutic Categories

Antiemetic agent

Histamine H₁-receptor antagonist (H₁-antihistaminic)

Chemical Name

Piperazine, 1-(diphenylmetyl)-4-metyl-

Foreign Names

  • Cyclizinum (Latin)
  • Cyclizin (German)
  • Cyclizine (French)
  • Ciclizina (Spanish)

Generic Names

  • Ciclizina (OS: DCIT)
  • Cyclizine (OS: BAN, DCF)
  • Cyclizine (PH: BP 2018, USP 23)
  • Cyclizine Hydrochloride (OS: BANM)
  • Cyclizine (chlorhydrate de) (PH: Ph. Eur. 9)
  • Cyclizine Hydrochloride (PH: BP 2018, USP 41)
  • Cyclizine hydrochloride (PH: Ph. Eur. 9)
  • Cyclizinhydrochlorid (PH: Ph. Eur. 9)
  • Cyclizini hydrochloridum (PH: Ph. Eur. 9, Ph. Int. 2)
  • Cyclizine Lactate (OS: BANM)
  • Cyclizine Tartrate (OS: BANM)

Brand Names

  • Emetrex
    Amoun, Egypt
  • Emetrex [+ Pyridoxine]
    Amoun, Egypt
  • Migril [+ Caffeine, + Ergotamine]
    GSK, Pakistan
  • Aculoid
    Pharmascript, South Africa
  • Adco-Cyclizine
    Al Pharm, South Africa
  • Cyclizine
    Concordia, United Kingdom
  • Cyclizine HCl CF
    Centrafarm, Netherlands
  • Cyclizine HCl Teva
    Teva Nederland, Netherlands
  • Cyclizine hydrochloride
    Concordia, United Kingdom
  • Cyclizine hydrochloride Central Procurement
    Central Procurement & Supplies Unit, Malta
  • Cyclizine hydrochloride Cherubino
    Cherubino, Malta
  • Cyclizine Hydrochloride P & D
    P & D, Malta
  • Diconal [+ Dipipanone]
    Concordia, United Kingdom
  • Echnatol
    Wabosan Arzneimittel, Austria
  • Echnatol B6 [+ Pyridoxine]
    Wabosan Arzneimittel, Austria
  • Etos Cyclizine HCl
    Etos, Netherlands
  • Gotur
    Orifarm Generics, Denmark
  • Liumpin
    Washington, Taiwan
  • Marzine
    GlaxoSmithKline, Taiwan; Meda, Denmark; Meda, Norway
  • Medazine
    MedPro, South Africa
  • Migril [+ Caffeine, + Ergotamine]
    Wockhardt UK, United Kingdom
  • Nausicalm
    AFT, New Zealand; AFT Pharmaceuticals, Australia
  • Nauzene
    Teva, New Zealand
  • Nauzine
    Be-Tabs Pharmaceuticals, South Africa
  • Reisfit [veterinary use]
    Beaphar, Netherlands
  • Triazine
    Pharmacare, South Africa
  • Valoid
    Concordia, Ireland; GlaxoSmithKline, South Africa
  • Cyclizine Central Procurement
    Central Procurement & Supplies Unit, Malta
  • Cyclizine Lactate
    Concordia, United Kingdom; hameln pharmaceuticals, United Kingdom; Phoenix, United Kingdom
  • Marzine
    GSK, Pakistan
  • Nausicalm
    AFT, New Zealand
  • Valoid
    AFT, New Zealand; Amdipharm Mercury, Australia; Concordia, Ireland
  • Valoid/Cyclizine Lactate
    Amdipharm, Malta
  • Cyclimorph [+ Morphine]
    Aspen Pharmacare, South Africa; Concordia, Ireland
  • Cyclimorph 10 [+ Morphine]
    Concordia, United Kingdom
  • Cyclimorph 15 [+ Morphine]
    Concordia, United Kingdom
  • Cyclizine Tartrate and Morphine Tartrate [+ Morphine]
    Concordia, United Kingdom


BANBritish Approved Name
BANMBritish Approved Name (Modified)
DCFDénomination Commune Française
DCITDenominazione Comune Italiana
OSOfficial Synonym
PHPharmacopoeia Name
Rec.INNRecommended International Nonproprietary Name (World Health Organization)

Further information on drug naming conventions: International Nonproprietary Names.

Important Notice: The international database is in BETA release. This means it is still under development and may contain inaccuracies. It is not intended as a substitute for the expertise and judgement of your physician, pharmacist or other healthcare professional. It should not be construed to indicate that the use of any medication in any country is safe, appropriate or effective for you. Consult with your healthcare professional before taking any medication.

Further information

Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.